Health Canada - Government of Canada
Skip to left navigationSkip over navigation bars to content
Drugs and Health Products

What's New

Files added to the Web site are also posted here in the What's New section for three weeks. Once you have browsed through the entire site, all you need to do to keep current is make sure you visit this page more than once every three weeks. The files will be available for downloading from here, and also have a link to the section in which they permanently live.

Weekly Drug NOC updates: November 12 - 16, 2007

Added on November 22, 2007

arrow Register of Innovative Drugs

Register of Innovative Drugs


Added on November 20, 2007

arrow

Quarterly Reports

Therapeutic Products Directorate (TPD) - 2007 Quarterly Drug Submission Performance Report - Part I

Biologics and Genetic Therapies Directorate (BGTD) - 2007 Quarterly Drug Submission Performance Report - Part II

Added on November 15, 2007

arrow

Special Access to Drugs & Health Products

Special Access Programme - Comprehensive Review

Special Access Programme Issue Identification Paper

Added on November 14, 2007

arrow

Summary Basis of Decision: Phase 1

Summary Basis Of Decision (SBD) ORTHO T. CRUZI ELISA TEST SYSTEM

Package Insert for ORTHO T. CRUZI ELISA TEST SYSTEM (PDF will open in a new window) Package Insert for ORTHO T. CRUZI ELISA TEST SYSTEM

arrow

Canada Gazette Part II

Food and Drug Regulations - Project 1491 - Schedule F Addition (SOR/2007-224)
Food and Drug Regulations - Project 1478 - Schedule F Addition (SOR/2007-224)
Food and Drug Regulations - Project 1512 - Schedule F Additions (SOR/2007-234)
Food and Drug Regulations - Project 1511 - Schedule F Addition (SOR/2007-234)
Food and Drug Regulations - Project 1502 - Schedule F Additions (SOR/2007-234)
Food and Drug Regulations - Project 1476 - Schedule F Additions (SOR/2007-234)

Added on November 13, 2007

arrow

eCTD

Health Canada posts validation rules for submissions provided in the eCTD format

arrow

Summary Basis of Decision: Phase 1

Notice of decision for AVAMYS

Added on November 8, 2007

arrow

Good Review Practices

Standard Operating Procedures (SOP) - Using the Pharmaceutical Safety and Efficacy Assessment Template (PSEAT) to Prepare Reports on Periodic Safety Update Reports for Products Authorized under the Notice of Compliance with Conditions Policy (PSUR-C)

Added on November 6, 2007

arrow

Summary Basis of Decision: Phase 1

Notice of decision for CUBICIN

Added on November 5, 2007

arrow

Summary Basis of Decision: Phase 1

Summary Basis of Decision (SBD) LYRICA

PDF Version Product Monograph Part III LYRICA

Added on October 31, 2007

arrow

Good Guidance Practices

Added on October 30, 2007

arrow

Summary Basis of Decision: Phase 1

Notice of decision for ATRIANCE

Added on October 25, 2007

arrow

Metabolic and Endocrine Therapies

Membership list

Added on October 25, 2007

arrow

Notice of Compliance with conditions (NOC/c)

Atriance


arrow

Metabolic and Endocrine Therapies

Agenda

Added on October 22, 2007

arrow

Metabolic and Endocrine Therapies

Announcement of meeting and invitation for stakeholder comments

Date Modified: 2007-11-23 Top